Class IIOngoingD-0651-2024
Drug recall · September 11, 2024
Tirzepatide 2 mL recall
Why: Lack of Assurance of Sterility
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Tirzepatide 2 mL (10 mg/mL) and 20 mg/mL, 2mL Multidose SC Injection vials, Compounded Rx Product, ProRx 267-565-7008, NDC 84139-210-01
- Lots / codes
Lot # ProRx040924-1, BUD 10/08/2024
- Quantity
- 37 vials
- Company
- ProRx LLC, Exton, PA
- Distribution
- Nationwide in the USA
- Initiated
- August 22, 2024 · Voluntary: Firm initiated
- Classified
- September 5, 2024
- Reported
- September 11, 2024
- How notified
- Letter
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Class IIOngoingSep 11, 2024SemaglutideProRx LLC · D-0650-2024Class IIOngoingSep 11, 2024SEMAGLUTIDE 5mg/2mLProRx LLC · D-0652-2024Class IIOngoingSep 11, 2024SEMAGLUTIDE 10mg/4mLProRx LLC · D-0653-2024Class IIOngoingSep 11, 2024Semaglutide / Cyanocobalamin Injection: 2.5/0.5 mg/mLProRx LLC · D-0654-2024Class IIOngoingSep 11, 2024TIRZEPATIDE 20 mg/2mLProRx LLC · D-0655-2024Class IIOngoingSep 11, 2024TIRZEPATIDE 60 mg/3mLProRx LLC · D-0656-2024
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.